These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 2764930
21. Phorbol esters alter muscarinic receptor binding and inhibit polyphosphoinositide breakdown in human neuroblastoma (SH-SY5Y) cells. Serra M, Smith TL, Yamamura HI. Biochem Biophys Res Commun; 1986 Oct 15; 140(1):160-6. PubMed ID: 3022714 [Abstract] [Full Text] [Related]
22. The selective protein kinase C inhibitor GF 109203X inhibits phorbol ester-induced morphological and functional differentiation of SH-SY5Y human neuroblastoma cells. Heikkilä J, Jalava A, Eriksson K. Biochem Biophys Res Commun; 1993 Dec 30; 197(3):1185-93. PubMed ID: 8280132 [Abstract] [Full Text] [Related]
23. Stimulation of tyrosine phosphorylation and mitogen-activated-protein (MAP) kinase activity in human SH-SY5Y neuroblastoma cells by carbachol. Offermanns S, Bombien E, Schultz G. Biochem J; 1993 Sep 01; 294 ( Pt 2)(Pt 2):545-50. PubMed ID: 7690547 [Abstract] [Full Text] [Related]
24. Elevated levels of protein kinase C activity and alpha-isoenzyme expression in murine peritoneal B cells. Cohen DP, Rothstein TL. J Immunol; 1991 May 01; 146(9):2921-7. PubMed ID: 2016532 [Abstract] [Full Text] [Related]
25. Muscarinic receptors in human SH-SY5Y neuroblastoma cell line: regulation by phorbol ester and retinoic acid-induced differentiation. Adem A, Mattsson ME, Nordberg A, Påhlman S. Brain Res; 1987 Jun 01; 430(2):235-42. PubMed ID: 3607514 [Abstract] [Full Text] [Related]
26. Activation of protein kinase C in permeabilized human neuroblastoma SH-SY5Y cells. Larsson C, Saermark T, Mau S, Simonsson P. J Neurochem; 1992 Aug 01; 59(2):644-51. PubMed ID: 1378489 [Abstract] [Full Text] [Related]
27. Staurosporine induces a neuronal phenotype in SH-SY5Y human neuroblastoma cells that resembles that induced by the phorbol ester 12-O-tetradecanoyl phorbol-13 acetate (TPA). Jalava A, Heikkilä J, Lintunen M, Akerman K, Påhlman S. FEBS Lett; 1992 Mar 30; 300(2):114-8. PubMed ID: 1348695 [Abstract] [Full Text] [Related]
28. Protein kinase C blocks somatostatin-induced modulation of calcium current in chick sympathetic neurons. Golard A, Role LW, Siegelbaum SA. J Neurophysiol; 1993 Oct 30; 70(4):1639-43. PubMed ID: 7506759 [Abstract] [Full Text] [Related]
29. Activation of Ras, Raf-1 and protein kinase C in differentiating human neuroblastoma cells after treatment with phorbolester and NGF. Söderholm H, Olsson A, Lavenius E, Rönnstrand L, Nånberg E. Cell Signal; 2001 Feb 30; 13(2):95-104. PubMed ID: 11257453 [Abstract] [Full Text] [Related]
30. A role for protein kinase C subtypes alpha and epsilon in phorbol-ester-enhanced K(+)- and carbachol-evoked noradrenaline release from the human neuroblastoma SH-SY5Y. Turner NA, Rumsby MG, Walker JH, McMorris FA, Ball SG, Vaughan PF. Biochem J; 1994 Jan 15; 297 ( Pt 2)(Pt 2):407-13. PubMed ID: 8297348 [Abstract] [Full Text] [Related]
31. Activation and protein kinase C-dependent nuclear accumulation of ERK in differentiating human neuroblastoma cells. Olsson AK, Vadhammar K, Nånberg E. Exp Cell Res; 2000 May 01; 256(2):454-67. PubMed ID: 10772818 [Abstract] [Full Text] [Related]
32. Regulation of [3H]phorbol-12,13-dibutyrate binding sites in mouse neuroblastoma cells: simultaneous down-regulation by phorbol esters and desensitization of their inhibition of muscarinic receptor function. Lai WS, el-Fakahany EE. J Pharmacol Exp Ther; 1988 Jan 01; 244(1):41-50. PubMed ID: 3422096 [Abstract] [Full Text] [Related]
33. Reversible and phorbol ester-specific defect of protein kinase C translocation in hepatocytes isolated from phenobarbital-treated rats. Brockenbrough JS, Meyer SA, Li CX, Jirtle RL. Cancer Res; 1991 Jan 01; 51(1):130-6. PubMed ID: 1988078 [Abstract] [Full Text] [Related]
34. PKC activity and protein phosphorylation in regulation of sIg mediated B cell activation. Lindsberg ML, Feuerstein N, Balapure AK, Mond JJ. Scand J Immunol; 1995 Feb 01; 41(2):194-201. PubMed ID: 7863266 [Abstract] [Full Text] [Related]
35. Translocation of the PKC isoforms present in the human neuroblastoma, SH-SY5Y, following short-term treatment with the phorbol ester, TPA. Goodall AR, Walker JH, Vaughan PF. Biochem Soc Trans; 1996 Aug 01; 24(3):427S. PubMed ID: 8878971 [No Abstract] [Full Text] [Related]
36. Structural requirements of lyngbyatoxin A for activation and downregulation of protein kinase C. Basu A, Kozikowski AP, Lazo JS. Biochemistry; 1992 Apr 21; 31(15):3824-30. PubMed ID: 1567838 [Abstract] [Full Text] [Related]
37. 12-O-tetradecanoylphorbol 13-acetate and forskolin modify muscarinic receptor-linked Ca2+ mobilization in SH-SY5Y neuroblastoma cells through different mechanisms. Akerman KE, Heikkilä JE. J Neurochem; 1990 Feb 21; 54(2):497-504. PubMed ID: 2299348 [Abstract] [Full Text] [Related]
38. Down-regulation or long-term inhibition of protein kinase C (PKC) reduces noradrenaline release evoked via either PKC-dependent or PKC-independent pathways in human SH-SY5Y neuroblastoma cells. Turner NA, Walker JH, Ball SG, Vaughan PF. Neurosci Lett; 1996 Dec 06; 220(1):37-40. PubMed ID: 8977143 [Abstract] [Full Text] [Related]
39. Modulation of protein kinase C-epsilon by phorbol esters in the monoblastoid U937 cell. Ways DK, Messer BR, Garris TO, Qin W, Cook PP, Parker PJ. Cancer Res; 1992 Oct 15; 52(20):5604-9. PubMed ID: 1394183 [Abstract] [Full Text] [Related]
40. Differentiation-associated decrease in muscarinic receptor sensitivity in human neuroblastoma cells. Heikkilä JE, Scott IG, Suominen LA, Akerman KE. J Cell Physiol; 1987 Jan 15; 130(1):157-62. PubMed ID: 3543028 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]